Are Renal Reference Intervals Required When Screening for Plasma Cell Disorders With Serum Free Light Chains and Serum Protein Electrophoresis?
Jude Abadie, Karen H. van Hoeven, J. Mitchell Wells
American Journal of Clinical Pathology, Vol. 131, Issue 2, pp. 166–171 (2009)
10.1309/ajcpr2m4euynhlgm
PMID: 19141376
Abstract
Renal impairment and polyclonal hypergammaglobulinemia may abnormally increase the serum free light chain (sFLC) ratio, giving false-positive results with current reference intervals. We measured sFLCs with concomitant serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP) in 281 patients. Results were interpreted relative to renal function (serum creatinine concentrations) and polyclonal hypergammaglobulinemia. Overall, 78 plasma cell disorders (PCDs) were detected with the serum panel of SPEP/sFLC vs 76 with SPEP/UPEP. In 13 samples with negative SPEP/UPEP, mildly increased ratios up to 3.1 (normal, 0.26-1.65) were observed: 10 were associated with increased serum creatinine and 1 with polyclonal hypergammaglobulinemia; 2 were unassociated with either condition. In 2 samples, decreased kappa/lambda ratios were identified that were clinically significant despite normal SPEP/UPEP. Two monoclonal gammopathies were identified with UPEP and sFLC, but samples were normal with SPEP. Screening for PCDs with a serum panel consisting of SPEP and the sFLC assays is a highly sensitive approach that could eliminate the need for UPEP. A mildly increased kappa/lambda ratio up to 3.1 was observed with increased serum creatinine and/or polyclonal hypergammaglobulinemia that was consistent with pathophysiologic changes, and, therefore, renal reference intervals are recommended.
Topics
Field: Biochemistry, Genetics and Molecular Biology · Subfield: Molecular Biology
Keywords
Serum protein electrophoresis,Hypergammaglobulinemia,Creatinine,Internal medicine,Medicine,Polyclonal antibodies,Gastroenterology,Immunology,Monoclonal,Antibody
MeSH Terms
UN Sustainable Development Goals
- Good health and well-being (0.62)
All Available Versions
- Landing page — American Journal of Clinical Pathology publishedVersion
- Landing page — PubMed publishedVersion
Citations by Year
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 1 | 2 | 3 | 1 | 2 | 2 | 1 | 2 |
- A monoclonal gammopathy precedes multiple myeloma in most patients 2009 · 571
- Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients 2011 · 48
- Are Renal Reference Intervals Required When Screening for Plasma Cell Disorders With Serum Free Light Chains and Serum Protein Electrophoresis? 2009 · 48
- Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population. 2006 · 43
- Albumin cobalt binding assay to rule out acute coronary syndrome. 2005 · 42
Continue on JournalsHub
Put what you just read into practice with these free tools.